Significance of serum apolipoprotein levels in assessing the degree of liver injury in patients with HBVrelated chronic liver disease
Xin-Yue Xing,Mei Liu,Su-Jun Zheng,Ying Zhang,Ju-Shan Wu,Hao Yu,Chang-Yong Li,Li Bai,Shuang Liu,Zhong-Ping Duan
2011-01-01
World Chinese Journal of Digestology
Abstract:AIM: To observe the changes in serum apolipoprotein levels in patients with HBV-related chronic liver disease and to assess the relationship between serum apolipoprotein levels and the degree of liver injury in these patients. METHODS: A total of 113 patients with HBVrelated chronic liver disease were involved in the study, including 33 patients with chronic hepatitis B, 46 patients with liver cirrhosis and 34 patients with liver failure. Patients with liver failure were further subdivided into good prognosis group and poor prognosis group. Fasting serum ApoA1 and ApoB levels were measured and MELD and Child-Pugh scores were calculated in these patients to analyze the correlation between the levels of serum apolipoproteins (including ApoA1, ApoB and ApoA1/B ratio) and liver disease scores (including MELD score and Child-Pugh score). RESULTS: Serum ApoA1 and ApoB levels were highest in the chronic hepatitis B group, followed by the liver cirrhosis group and liver failure group (F = 41.592, P = 0.000; F = 9.178, P = 0.000; ApoA1/B ratio: 1.31 ± 0.73, 1.38 ± 0.65, 0.51 ± 0.38, F = 22.759, P = 0.000). Serum ApoA1 levels and ApoA1/B ratio were not statistically different between the chronic hepatitis B group and liver cirrhosis group (P = 0.057, 0.625), but were significantly lower in the liver failure group than in the other two groups (both P = 0.000). Serum ApoB levels did not differ significantly between patients with liver cirrhosis and those with hepatic failure (P = 0.082), but were significantly lower in the chronic hepatitis B group than in the other two groups (P = 0.006, 0.000). Child-Pugh and MELD scores were lowest in the chronic hepatitis B group, followed by the liver cirrhosis group and liver failure group (F = 74.961, P = 0.000; F = 56.405, P = 0.000). In patients with HBV-related chronic liver disease, serum levels of ApoA1 and ApoB and ApoA1/B ratio were negatively correlated with Child-Pugh and MELD scores (all P < 0.05). In the liver failure group, serum levels of ApoA1 and ApoB, ApoA1/B ratio, Child-Pugh and MELD scores showed no significant difference between the good and poor prognosis groups (all P > 0.05). CONCLUSION: Serum levels of ApoA1, ApoB and ApoA1/ApoB ratio are good parameters to reflect the degree of liver injury in patients with HBV-related chronic liver disease.